{
    "eid": "2-s2.0-85081145208",
    "title": "Immunogenicity and Adverse Reactions to Biosimilar Erythropoietin Products in Thailand: The Significance of Science and Quality Driven Process for Approval",
    "cover-date": "2018-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pharmaceutical Science",
            "@code": "3003",
            "@abbrev": "PHAR"
        }
    ],
    "keywords": [
        "Immunogenicity of recombinant human erythropoietin (r-HuEpo)",
        "Pure red cell aplasia (PRCA)",
        "Renal anemia"
    ],
    "authors": [
        "Kearkiat Praditpornsilpa",
        "Anunchai Assawamakin",
        "Kriang Tungsanga"
    ],
    "citedby-count": 0,
    "ref-count": 50,
    "ref-list": [
        "Pure red-cell aplasia and epoetin therapy",
        "The economics of biosimilars",
        "The increased incidence of pure red cell aplasia with an Eprex formulation in uncoated rubber stopper syringes",
        "The future of host cell protein (HCP) identification during process development and manufacturing linked to a risk-based management for their control",
        "Antibodies against r-HuEPO: Native or recombinant",
        "Pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin",
        "Biosimilars need comparative clinical data",
        "Characterizing biological products and assessing comparability following manufacturing changes",
        "Biosimilar epoetins: An analysis based on recently implemented European medicines evaluation agency guidelines on comparability of biopharmaceutical proteins",
        "Biophysical comparability of the same protein from different manufacturers: A case study using Epoetin alfa from Epogen\u00ae and Eprex",
        "Production of recombinant proteins by microbes and higher organisms",
        "How the biologics landscape is evolving",
        "Pure red cell aplasia",
        "Case-control study of the association between select HLA genes and anti-erythropoietin antibody-positive pure red-cell aplasia",
        "Development of an inductively coupled plasma mass spectrometry method for quantification of extracted tungsten from glass prefilled syringes used as a primary packaging for pharmaceutical and therapeutic protein products",
        "Safety, immunogenicity and efficacy of subcutaneous biosimilar epoetin-\u03b1 (HX575) in non-dialysis patients with renal anemia: A multi-center, randomized, double-blind study",
        "How bio-questionable are the different recombinant human erythropoietin copy products in Thailand?",
        "Protein isolated from biopharmaceutical formulations cannot be used for comparative studies: Follow-up to \u201ca case study using Epoetin Alfa from Epogen and EPREX\u201d",
        "HLA-B * 5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol",
        "Extractable/leachable substances from plastic materials used as pharmaceutical product containers/devices",
        "WHO informal consultation on regulatory evaluation of therapeutic biological medicinal products held at WHO Headquarters",
        "Resistance to erythropoietin",
        "Pure red-cell aplasia \u2018epidemic\u2019\u2013 mystery completely revealed?",
        "Antibody-mediated pure red cell aplasia in chronic kidney disease patients receiving erythropoiesis-stimulating agents: New insights",
        "PRIMS Study Group. Incidence of erythropoietin antibody-mediated pure red cell aplasia: The prospective immunogenicity surveillance registry (PRIMS)",
        "Association between presence of HLA-B * 5701, HLA-DR-7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir",
        "Successful resumption of epoetin alfa after rituximab treatment in a patient with pure red cell aplasia",
        "Endotoxin-free dialysate improves response to erythropoietin in hemodialysis patients",
        "Improved plasma culture system for production of erythrocytic colonies in vitro: Quantitative assay method for CFU-E",
        "Immunogenicity of therapeutic protein aggregates",
        "Biochemical assessment of erythropoietin products from Asia versus US Epoetin Alfa manufactured by Amgen",
        "Antibodies against recombinant human erythropoietin in a patient with erythropoietin resistance anemia",
        "Human immune response to recombinant human proteins",
        "Antibodies to recombinant human erythropoietin causing pure red cell aplasia",
        "Recovery from anti-recombinant-human-erythropoietin associated pure red cell aplasia in end-stage renal disease patients after renal transplantation",
        "The association of anti-r-HuEpo-associated pure red cell aplasia with HLA-DRB1 09-DQB1 0309",
        "Biosimilar recombinant human erythropoietin induces the production of neutralizing antibodies",
        "Rechallenge with intravenous recombinant human erythropoietin can be successful following the treatment of anti-recombinant erythropoietin associated pure red cell aplasia",
        "Dendritic-cell trafficking to lymph nodes through lymphatic vessels",
        "An in vivo model to assess factors that may stimulate the generation of an immune reaction to erythropoietin",
        "Manufacturing of biodrugs: Need for harmonization in regulatory standards",
        "When biotech proteins go off-patent",
        "Tungsten-induced denaturation and aggregation of epoetin Alfa during primary packaging as a cause of immunogenicity",
        "Pure red cell aplasia induced only by intravenous administration of recombinant human erythropoietin",
        "Effects of glycosylation on the stability of protein pharmaceuticals",
        "Towards regulation of similar biotherapeutic products: Thailand\u2019s perspective",
        "Thailand: Health care for all, at a price",
        "Rapid method for detection of anti-recombinant human erythropoietin antibodies as a new form of erythropoietin resistance",
        "Biopharmaceutical benchmarks 2014"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nakhon Pathom",
            "@id": "60012718",
            "affilname": "Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012718",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}